Superworth

Verrica Pharmaceuticals market cap VRCA

Share price times shares outstanding: what the whole company sells for, since 2018.

Today, Nov 2, 2026
$55.1M
Highest close in our data
$452.3M
Aug 2018

Verrica Pharmaceuticals is worth $55.1M at the close on Nov 2, 2026, at $3.21 a share.

That is up 69% over the last year and down 85% over five years.

Its highest close in our data was $452.3M in Aug 2018.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$55.1M$50.4M$137.3M−29%
2025$77.4M$27.7M$86.4M+148%
2024$31.2M$31.2M$367.8M−90%
2023$307.9M$129.3M$330.4M+172%
2022$113M$55M$249.6M−55%
2021$252.1M$250.4M$437.9M−15%
2020$297.7M$169.1M$410.1M−27%
2019$409.3M$183.3M$409.3M+81%
2018$225.6M$173.5M$452.3Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Verrica Pharmaceuticals' size, closest first, today.

CompanyMarket cap
VRCAVerrica Pharmaceuticals$55.1M
SPROSpero Therapeutics$60.6M
ATNMActinium Pharmaceuticals$45M
LFVNLifevantage$73.5M
NATRNatures Sunshine Products$211.5M
CRMDCorMedix$420.1M
ARVNArvinas$491.7M
PBYIPuma Biotechnology$525.5M
Peer median$211.5M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Verrica Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.